Korea Business News

Acute Repetitive Seizures Market Size, Share, Growth and Forecast 2019-2026

Press release   •   Sep 24, 2019 16:51 GMT

The global acute repetitive seizures market size is expected to reach USD 3.70 billion by 2026 and forecasted to grow at a strong CAGR of 47.8% during the forecast period 2019 to 2026.

The report analyzes and forecasts the acute repetitive seizures market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

Get the Sample Copy of Report@ https://www.visionresearchreports.com/report/sample/20709

This report first introduces the background of acute repetitive seizures, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major acute repetitive seizures companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of acute repetitive seizures upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of acute repetitive seizures and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global acute repetitive seizures market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the acute repetitive seizures market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Request to Buy this Premium Report From Here@ https://www.visionresearchreports.com/report/cart/20709

The report provides size (in terms of volume and value) of acute repetitive seizures market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Major market members in the Global Acute Repetitive seizure Market identified across the value chain include:, Valeant Pharmaceuticals, Alexza Pharmaceuticals, Veriton Pharma Limited, Sanofi, Pfizer Inc., Neurelis, UCB S.A., Neurelis, Inc and others. Also there are many emerging therepies from manufacturers such as Acorda Therapeutics, Inc., Upsher-Smith Laboratories, LLC, Epalex and others.

Further key findings from the study suggest:

  • Global acute repetitive seizures market size was estimated at USD 140.5 million in 2017 and is expected to register a CAGR of 47.8% over the forecast period
  • Diastat rectal gel was the dominant product segment in 2017 due to efficacy of the route of administration and affordability of the product
  • USL-261 is expected to witness a lucrative CAGR over the forecast period. USL-21 has an edge over the other drugs owing to its superior clinical profile and positive phase III results
  • North America held the largest share in 2017 due to factors, such as growing initiatives for raising awareness about epilepsy and seizures
  • Germany is anticipated to witness lucrative growth over the next decade owing to technological advancements in scientific, clinical, and medical fields

Market Segmentation

Market By Product

  • USL-261
  • NRL-1
  • AZ-002
  • Diastat Rectal Gel
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East
    • Saudi Arabia
    • UAE
    • Rest of Middle East
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Africa
    • South Africa
    • Egypt
    • Rest of Africa

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global acute repetitive seizures capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
  • Market value USD Million and volume Units Million data for each segment and sub-segment
  • Focuses on the key acute repetitive seizures manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content

Chapter 1. Industry Overview
1.1 Definition and Scope
1.1.1 Definition of Acute Repetitive Seizures
1.1.2 Market Segmentation
1.2 Summary
1.2.1 Market Snapshot
1.2.2 Acute Repetitive Seizures Market, By Product
1.2.2.1 Global Acute Repetitive Seizures Market Revenue (USD Million) Comparison, By Product (2016-2026)
1.2.2.2 Global Acute Repetitive Seizures Market Revenue (USD Million)Share, By Product in 2026
1.2.2.3 USL-261
1.2.2.4 NRL-1
1.2.2.5 AZ-002
1.2.2.6 Diastat Rectal Gel
1.2.3 Acute Repetitive Seizures Market by Geography
1.2.3.1 Global Acute Repetitive Seizures Market Revenue (USD Million) and Growth Rate Comparison by Geography (2016-2026)
1.2.3.2 North America Acute Repetitive Seizures Market Revenue (USD Million) (2016-2026)
1.2.3.3 Europe Acute Repetitive Seizures Market Revenue (USD Million) (2016-2026)
1.2.3.4 Asia-Pacific Acute Repetitive Seizures Market Revenue (USD Million) (2016-2026)
1.2.3.5 Latin America Acute Repetitive Seizures Market Revenue (USD Million) (2016-2026)
1.2.3.6 Middle East Acute Repetitive Seizures Market Revenue (USD Million)(2016-2026)
1.2.3.7 Africa Acute Repetitive Seizures Market Revenue (USD Million) and Growth Rate (2016-2026)
Chapter 2. Market Dynamics and Competition Analysis
2.1 Market Drivers
2.1.1 Increasing prevalence of neurological diseases
2.1.2 Strong pipeline products and the increasing number of regulatory approvals
2.2 Restraints and Challenges
2.2.1 Lack of awareness pertinent to the management of acute repetitive seizures
2.3 Growth Opportunities
2.3.1 The shift from rectal to the nasal route of administration
2.4 Porter’s Five Forces Analysis
2.4.1 Bargaining Power of Suppliers
2.4.2 Bargaining Power of Buyers
2.4.3 Threat of Substitute
2.4.4 Threat of New Entrants
2.4.5 Degree of Competition
2.5 Value Chain Analysis
2.6 Pipeline Drug Analysis of Acute Repetitive Seizures
2.6.1 Raw Material and Suppliers
2.6.2 Manufacturing Process Analysis
2.7 Regulatory Compliance
2.8 Competitive Landscape, 2017
2.8.1 Player Positioning Analysis
2.8.2 Key Strategies Adopted By Leading Players
Chapter 3. Manufacturing Plants Analysis
3.1 Manufacturing Plants Distribution of Global Acute Repetitive Seizures Major Manufacturers in 2017
3.2 R&D Status and Technology Source of Global Acute Repetitive Seizures Major Manufacturers in 2017
3.3 Raw Materials Sources Analysis of Global Acute Repetitive Seizures Major Manufacturers in 2017
Chapter 4. Acute Repetitive Seizures Market By Product
4.1 Global Acute Repetitive Seizures Revenue (USD Million), By Product
4.2 USL-261
4.2.1 Market Revenue (USD Million) and Growth Rate, 2016 - 2026
4.2.2 USD-261 Market Revenue (USD Million) and Forecast, By Region, 2016 - 2026
4.3 NRL-1
4.3.1 Market Revenue (USD Million) and Growth Rate, 2016–2026
4.3.2 NRL-1 Market Revenue (USD Million) and Forecast, By Region, 2016 - 2026
4.4 AZ-002
4.4.1 Market Revenue (USD Million) and Growth Rate, 2016 - 2026
4.4.2 AZ-002 Market Revenue (USD Million) and Forecast, By Region, 2016 - 2026
4.5 Diastat Rectal Gel
4.5.1 Market Revenue (USD Million) and Growth Rate, 2016 - 2026
4.5.2 Diastat Rectal GelMarketRevenue (USD Million) and Forecast, By Region, 2016 - 2026
4.6 Others
4.6.1 Market Revenue (USD Million) and Growth Rate, 2016 - 2026
4.6.2 Other Market Revenue (USD Million) and Forecast, By Region, 2016 - 2026
Chapter 5. North America Acute Repetitive Seizures Market By Country
5.1 North America Acute Repetitive Seizures Market Revenue (USD Million), 2016 - 2026
5.2 North America Acute Repetitive Seizures Market Revenue (USD Million) Share Comparison, 2016& 2026 (%)
5.3 U.S.
5.3.1 U.S. Acute Repetitive Seizures Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
5.4 Canada
5.4.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
5.5 Mexico
5.5.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
Chapter 6. Europe Acute Repetitive Seizures Market, By Country
6.1 Europe Acute Repetitive Seizures Market Revenue (USD Million), 2016 - 2026
6.2 Europe Acute Repetitive Seizures Market Revenue (USD Million) Share Comparison, 2016& 2026 (%)
6.3 UK
6.3.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
6.4 Germany
6.4.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
6.5 France
6.5.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
6.6 Rest of Europe
6.6.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
Chapter 7. Asia-Pacific Acute Repetitive Seizures Market, By Country
7.1 Asia-Pacific Acute Repetitive Seizures Market Revenue (USD Million), 2016 - 2026
7.2 Asia Pacific Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
7.3 China
7.3.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
7.4 Japan
7.4.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
7.5 India
7.5.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
7.6 Australia
7.6.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
7.7 South Korea
7.7.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
7.8 Rest of Asia-Pacific
7.8.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
Chapter 8. Latin America Acute Repetitive Seizures Market, By Country
8.1 Latin America Acute Repetitive Seizures Market Revenue (USD Million), by Country, 2016 - 2026
8.2 Latin America Acute Repetitive Seizures Market Revenue (USD Million), by Product, 2016 - 2026
8.3 Latin America Acute Repetitive Seizures Market Revenue (USD Million) Share Comparison, 2016& 2026 (%)
8.4 Brazil
8.4.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
8.5 Argentina
8.5.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
8.6 Rest of Latin America
8.6.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
Chapter 9. Middle East Acute Repetitive Seizures Market, By Country
9.1 Middle East Acute Repetitive Seizures Market Revenue (USD Million), By Country,2016 - 2026
9.2 Middle East Acute Repetitive Seizures Market Revenue (USD Million), By Product, 2016 - 2026
9.3 Middle East Acute Repetitive Seizures Market Revenue (USD Million) Share Comparison, 2016& 2026 (%)
9.4 Saudi Arabia
9.4.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
9.5 UAE
9.5.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
9.6 Rest of Middle East
9.6.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
Chapter 10. Africa Acute Repetitive Seizures Market By Country
10.1 Africa Acute Repetitive Seizures Market Revenue (USD Million), By Region, 2016 - 2026
10.2 Africa Acute Repetitive Seizures Market Revenue (USD Million), By Product, 2016 - 2026
10.3 Africa Acute Repetitive Seizures Market Revenue (USD Million) Share Comparison, 2016 & 2026 (%)
10.4 South Africa
10.4.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
10.5 Egypt
10.5.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
10.6 Rest of Africa
10.6.1 Market Revenue (USD Million) and Forecast, By Product, 2016 - 2026
Chapter 11. Company Profile
11.1 Grupo Ferrer Internacional S.A. (ALEXZA)
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Pipeline Analysis
11.1.4 Recent Development
11.1.5 Strategies
11.2 Neurelis, Inc.
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Pipeline Analysis
11.2.4 Recent Developments
11.2.5 Strategies
11.3 UCB S.A.
11.3.1 Company Snapshot
11.3.2 Overview
11.3.3 Financial Overview, 2015-2017, (USD MILLION
11.3.1 R&D Investment
11.3.2 Pipeline Analysis
11.3.3 Key Developments
11.3.4 Strategies
Chapter 12. Research Approach
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.2 Market Size Estimation
12.3 Market Breakdown and Data Triangulation
12.4 Data Source
12.4.1 Secondary Sources
12.5 Primary Sources

12.6 Report Scope

Request to Buy this Premium Report From Here@ https://www.visionresearchreports.com/report/cart/20709